Arbro Pharmaceuticals Private Limited

Manufacturer and exporter of pharmaceutical formulations for human and veterinary use, with over 700 products.

1985 | Active
Last Updated:

Arbro Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.99 Cr
  • Paid Up Capital ₹ 1.78 Cr
  • Company Age 39 Year, 10 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 14.82 Cr
  • Satisfied Charges ₹ 13.70 Cr
  • Revenue Growth 86.43%
  • Profit Growth -5.76%
  • Ebitda -11.91%
  • Net Worth 5.83%
  • Total Assets 6.50%

About Arbro Pharmaceuticals

Arbro Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 June 1985 and has a history of 39 years and ten months. Its registered office is in Na, Delhi.

The Corporate was formerly known as Arbro Pharmaceuticals Ltd.. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.99 Cr and a paid-up capital of Rs 1.78 Cr.

The company currently has active open charges totaling ₹14.82 Cr. The company has closed loans amounting to ₹13.70 Cr, as per Ministry of Corporate Affairs (MCA) records.

Vijay Arora, Saurabh Arora, and Sunil Jaitly serve as directors at the Company.

Company Details

  • Location Na, Delhi
  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232DL1985PTC021362

  • Company No.

    021362

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    28 Jun 1985

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

What products or services does Arbro Pharmaceuticals Private Limited offer?

Arbro Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Cancer Medicines, Evertor Tablet, Common Disease Medicines, Pharmaceutical Tablets, Casodex Tablet, Antiviral Drugs, Inosine Pranobex Tablets, TB, Tumor & Cancer Drugs, Brain & Nervous System Drugs, Psychotherapeutic Agents.

Company report

Arbro Pharmaceuticals Private Limited

Explore comprehensive data for Arbro Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Arbro Pharmaceuticals?

Executive Team (1)

NameDesignationAppointment DateStatus
Vijay Arora Country flag representing In Managing Director28-Jun-1985Current

Board Members (2)

NameDesignationAppointment DateStatus
Saurabh Arora Country flag representing In Director 05-Aug-2005Current
Sunil Jaitly Country flag representing In Whole-Time Director 05-Dec-1998Current

Financial Performance of Arbro Pharmaceuticals.

Arbro Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 86.43% increase. The company also saw a slight decrease in profitability, with a 5.76% decrease in profit. The company's net worth moved up by a moderate rise of 5.83%.

Arbro Pharmaceuticals revenue growth over time
Arbro Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
86.43%
Revenue from Operations
86.36%
Total Assets
6.50%
Profit or Loss
-5.76%
Net Worth
5.83%
EBITDA
-11.91%

What is the Ownership and Shareholding Structure of Arbro Pharmaceuticals?

In 2023, Arbro Pharmaceuticals had a promoter holding of 99.99% and a public holding of 0.01%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹14.82 Cr

Satisfied Charges

₹13.70 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 14.40 Cr
  • Department Of Biotechnology : 0.32 Cr
  • Others : 0.07 Cr
  • Icici Bank Limited : 0.04 Cr

Latest Charge Details

DateLenderAmountStatus
08 Mar 2021Hdfc Bank Limited₹1.79 MOpen
28 Aug 2020Hdfc Bank Limited₹0.52 MOpen
28 Aug 2018Hdfc Bank Limited₹0.41 MOpen
28 Aug 2018Hdfc Bank Limited₹0.43 MOpen
28 Aug 2018Hdfc Bank Limited₹0.49 MOpen

How Many Employees Work at Arbro Pharmaceuticals?

Arbro Pharmaceuticals has a workforce of 369 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Arbro Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Arbro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arbro Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Arbro Pharmaceuticals

Recent activity within the organization

  • Charges

    A charge with Hdfc Bank Limited of Rs. 14.03 Cr registered on 23 May 2017 with Charge ID 100104599 was modified on 21 Mar 2024.

  • Annual General Meeting

    Arbro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Arbro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 100440973 was registered on 08 Mar 2021.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.05 Cr with Charge ID 100388037 was registered on 28 Aug 2020.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.04 Cr with Charge ID 100204454 was registered on 28 Aug 2018.

Frequently asked questions

  • What is the Incorporation or founding date of Arbro Pharmaceuticals Private Limited?

    Arbro Pharmaceuticals Private Limited was incorporated on 28 Jun 1985.

  • What is authorized share capital and paid-up capital of Arbro Pharmaceuticals Private Limited?

    The authorized share capital of Arbro Pharmaceuticals Private Limited is ₹ 1.99 Cr and paid-up capital is ₹ 1.78 Cr.

  • Who are the current board members & directors of Arbro Pharmaceuticals Private Limited?

    Currently 3 directors are associated with Arbro Pharmaceuticals Private Limited.

    • Vijay Kumar Arora
    • Saurabh Arora
    • Sunil Kumar Jaitly

  • What is the registered address of Arbro Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Arbro Pharmaceuticals Private Limited is 6/14 Kirti Gar Industrialarea, New India, Na, Delhi.

  • What is the corporate identification number (CIN) and company number of Arbro Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Arbro Pharmaceuticals Private Limited is U24232DL1985PTC021362 and the company number is 021362 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Arbro Pharmaceuticals Private Limited?

    The Official website of Arbro Pharmaceuticals Private Limited is https://www.arbropharma.com

  • What has been the recent revenue trend for Arbro Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Arbro Pharmaceuticals Private Limited has risen by 86.43%.

  • How many employees does Arbro Pharmaceuticals Private Limited currently have?

    As Per 2023 financial reports, 369 employees are currently employed by Arbro Pharmaceuticals Private Limited.

  • What change has been observed in the net worth of Arbro Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Arbro Pharmaceuticals Private Limited has experienced an upsurge of 5.83%.

  • What are the total open charges for Arbro Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Arbro Pharmaceuticals Private Limited amount to ₹ 14.82 Cr.

  • When was the last Balance Sheet of Arbro Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Arbro Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Animal Pharmaceuticals & Healthcare